ARTO:EURONEXT PARISSociete Industrielle & Financiere de l'Artois SA Analysis
Data as of 2026-06-10 - not real-time
€9,100.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock trades at 9,100 €, comfortably above the 20‑day (9,085 €) and 50‑day (9,060 €) moving averages and the 200‑day level (8,838 €), indicating short‑term price momentum. Volume is increasing and the RSI sits near the neutral 52 mark, while the MACD histogram is negative, signaling a bearish divergence that could temper the bullish trend. Beta is low at 0.32 and 30‑day volatility is moderate at 16 %, suggesting limited price swings relative to the market.
Fundamentally, the company appears severely overvalued with a trailing P/E of 294 versus an industry average of 35, and revenue has fallen 15 % year‑over‑year. Operating and EBITDA margins are negative, cash‑flow generation is weak, and the dividend payout ratio exceeds 200 %, raising serious doubts about dividend sustainability. The balance sheet shows a high debt‑to‑equity of 3.1, while ROE is near zero, highlighting financial fragility despite a modest market cap.
Fundamentally, the company appears severely overvalued with a trailing P/E of 294 versus an industry average of 35, and revenue has fallen 15 % year‑over‑year. Operating and EBITDA margins are negative, cash‑flow generation is weak, and the dividend payout ratio exceeds 200 %, raising serious doubts about dividend sustainability. The balance sheet shows a high debt‑to‑equity of 3.1, while ROE is near zero, highlighting financial fragility despite a modest market cap.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price above key moving averages supports near‑term momentum
- Increasing volume indicates trader interest
- Bearish MACD histogram warns of potential pullback
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Trailing P/E of 294 far exceeds industry norm
- Negative earnings, cash flow and a 15 % revenue decline
- Dividend payout ratio over 200 % is unsustainable
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- High debt‑to‑equity ratio (3.1) stresses the balance sheet
- Near‑zero ROE and negative ROA indicate poor capital efficiency
- Low beta and moderate volatility provide limited upside in a turnaround
Key Metrics & Analysis
Financial Health
Revenue Growth-15.10%
Profit Margin6.09%
P/E Ratio294.1
ROE0.04%
ROA-0.35%
Debt/Equity3.10
P/B Ratio1.1
Op. Cash Flow€-14430000
Free Cash Flow€-2912125
Industry P/E35.2
Technical Analysis
TrendBullish
RSI52.0
Support€9,000.00
Resistance€9,200.00
MA 20€9,085.00
MA 50€9,060.00
MA 200€8,838.00
MACDBearish
VolumeIncreasing
Fear & Greed Index81.75
Valuation
GradeOvervalued
TypeValue
Dividend Yield0.75%
Risk Assessment
Beta0.32
Volatility16.20%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.